Cargando…
(18)F‐FDG PET/CT features of immune‐related adverse events and pitfalls following immunotherapy
(18)F‐FDG PET/CT scanning is routinely performed to stage and evaluate the treatment response in many malignancies. Immunotherapy is a rapidly growing treatment option for many cancers, and both clinicians and imaging specialists need to be familiar with (18)F‐FDG PET/CT imaging characteristics uniq...
Autores principales: | Cherk, Martin H, Nadebaum, David P, Barber, Thomas W, Beech, Paul, Haydon, Andrew, Yap, Kenneth S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303622/ https://www.ncbi.nlm.nih.gov/pubmed/35191204 http://dx.doi.org/10.1111/1754-9485.13390 |
Ejemplares similares
-
Computational approaches to detect small lesions in (18)F‐FDG PET/CT scans
por: Nichols, Kenneth J., et al.
Publicado: (2021) -
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [(18)F]FDG-PET/CT
por: Enke, Johanna S., et al.
Publicado: (2023) -
(18)F-FDG PET/CT Findings in Cytomegalovirus Colitis
por: Kjaer, Anna Sophie L., et al.
Publicado: (2018) -
Incidental “Urinoma” in (18)F-FDG PET/CT Scan
por: Gültekin, Aziz, et al.
Publicado: (2019) -
Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
por: Fonti, Rosa, et al.
Publicado: (2020)